100% found this document useful (1 vote)
225 views20 pages

Defibrillation and Drug Protocols in ACLS

This document outlines drug therapies and defibrillation protocols for ventricular fibrillation (VF) and ventricular tachycardia (VT) during cardiac arrest. It recommends defibrillating at 200, 300, and 360 Joules and alternating defibrillation with drug therapies like epinephrine, lidocaine, bretylium, magnesium sulfate, procainamide, and sodium bicarbonate. Epinephrine may help restore spontaneous circulation in short-duration arrests. Lidocaine is first-line for ventricular arrhythmias while bretylium is second-line. Procainamide and magnesium sulfate are used for refractory VT.

Uploaded by

Afrida Sahestina
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPT, PDF, TXT or read online on Scribd
100% found this document useful (1 vote)
225 views20 pages

Defibrillation and Drug Protocols in ACLS

This document outlines drug therapies and defibrillation protocols for ventricular fibrillation (VF) and ventricular tachycardia (VT) during cardiac arrest. It recommends defibrillating at 200, 300, and 360 Joules and alternating defibrillation with drug therapies like epinephrine, lidocaine, bretylium, magnesium sulfate, procainamide, and sodium bicarbonate. Epinephrine may help restore spontaneous circulation in short-duration arrests. Lidocaine is first-line for ventricular arrhythmias while bretylium is second-line. Procainamide and magnesium sulfate are used for refractory VT.

Uploaded by

Afrida Sahestina
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPT, PDF, TXT or read online on Scribd

DRUGS AND DEFIBRILLATION

Department of Anesthesiology & Reanimation General Hospital Tasikmalaya

(D) Defibrilate VF and VT (if identified)


The

initial call for help should result defibrillator Hunt for VF/VT 90% who survives sudden non traumatic cardiac arrest was resuscitated from VF The success of defibrillation is remarkably time dependent

Survival rate of early defibrillation

VF/VT Pulseless Algorithm


The most important algorithm in all of ACLS
The reason : VF/VT occur often, are lethal and correctable more often than asystole and PEA The first rule is shock early and often, continuing to alternate defibrillation attempts with attempts at drug therapy until you succeed or until the patient goes to another algorithm

Ventricular Tachycardia

Ventricular Fibrillation

Algorithm VF/VT :

Defibrillate 200J Defibrillate 200-300J Defibrillate 360J Hypothermic? Yes Hypothermia

Spontaneous circulation Vital Sign Support breathing Provide appropriate med.

VF/VT Intubate Continue CPR Obtain IV access

PEA

Asystole

Epinephrine 1mg every 3-5 min


Lidocaine 1.5-2 mg/kg repeat in 3-5 min Bretylium 5 mg/kg repeat in 5 min at 10 mg/kg MgSO4 1-2 gr in susp HypoMg or refractory VF Choose medication Procainamide 15 mg/kg at 30 mg/min BicNat 1 meq/kg Defibrillate 360J after 30-60 sec.

Defibrillation
Used

firstly 3 times in Ventricular Fibrillation Dose : 200 Joule 300 Joule 360 Joule Drug Shock Drug Shock Pediatric dose : 2 J/kg 4 J/kg

Defibrillation
Used

firstly 3 times in Ventricular Fibrilatin Dose : 200 Joule 300 Joule 360 Joule Drug Shock Drug Shock Pediatric dose : 2 mg/kg 4 mg/kg

Epinephrine ( Adrenaline )
may help restore spontaneous circulation in cardiac arrest of 1 2 minute duration
Alpha and beta receptor activity Alpha receptor activity is the most important in cardiac arrest Dose : 1 mg IV, can be repeated every 3-5 min.

Epinephrine ( Adrenaline )
Alfa adrenergic : promote peripheral vascular vasoconstriction increase of diastolic pressure

improve coronary circulation


preserve myocardial oxygenation greater possibilities of spontaneous heart contraction

Lidocaine
Pharmacologic action: 1. Decreases automaticity 2. Depresses conduction in reentrant pathways 3. May raise fibrillation threshold, especially in combination with bretylium Uses: The drug of first choice for ventricular arrhythmias ventricular ectopy, and wide complex tachycardias of unknown origin.

Lidocaine
Dose: 1- 2 mg/kg IV bolus, followed by additional 0.5-1.5 mg/kg every 5-10 min to a total of 3 mg/kg Can be administered via the endotracheal tube. Use 2 to 2.5 times the intravenous dose. Upon return of circulation, use continuous infusion at 2 - 4 mg/min. Reduce the maintenance dose if decreased cardiac output or hepatic failure or more than 70 years of age. Pediatric infusion: 20-50 mcg/kg per min

Lidocaine
Potential complications: Dizziness, drowsiness, disorientation, seizures Hypotension - causes vasodilation; myocardial depression at higher concentrations Heart block - only rarely seen with high levels

Bretylium

Antiarrhythmic, as second line drug after lidocaine Dose : 5 mg/kg or as initial dose 500 mg Repeat in 5 min at 10 mg/kg Total dose : 35 mg/kg (or 2 more doses of 10 mg/kg at 5-30 min) At persistent VT, loading 500 mg/8 10 min,followed by continous infusion at 2 mg/min Initial : sympathomimetic , after steady state : sympatholytic Side Efect : Hypertension Hypotension

Magnesium Sulfate
Dose

: 1 2 gr, if suspected hypomagnesemia or refractory VT

Procainamide
Antiarrhythmic

Dose

15 mg/kg at 30 mg/min Indication : VF, VT, Atrial tachyarrhythmia Second line drug during arrest Third line antiarrhythmic used after lidocaine and bretylium Second line drug in VT after lidocaine failed

Sodium Bicarbonate
Pharmacologic action: Acid neutralization Uses: 1. Preexisting metabolic acidosis (pH < 7) 2. Hyperkalemia 3. Tricyclic or phenobarbital overdose

Dose: Initial: 1 mEq/kg IV bolus Subsequent doses: 0.5 mEq/kg IV every 10 min

Sodium Bicarbonate
Potential complications: 1. Metabolic alkalosis 2. Hypercarbia 3. Hyperosmolar state Note: Since HCO3- does not cross cell membranes and CO2 does, the administration of bicarbonate may actually make tissues more acidotic.

You might also like